ReviewFrontiers in immunology2026
Obesity-driven low-grade chronic inflammation as a mechanistic bridge to chronic pain: from adipose tissue remodeling to central sensitization.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obesity and chronic pain co-occur at high rates, yet the mechanistic logic that connects metabolic excess to persistent nociception remains fragmented across separate literatures. This review integrates these literatures around a single guiding question: how does chronic energy overload become a sensitized nervous system that no longer self-terminates? We propose a Metabolic-Immune-Neural (MIN) triangle hypothesis and trace a four-step causal chain. First, adipose tissue remodeling-hypertrophy, hypoxia, ER stress, lipid spillover, and metabolic endotoxemia-generates the molecular precursors of inflammation. Second, immune-cell remodeling and immunometabolic reprogramming amplify these signals, and trained immunity inscribes an epigenetic memory in myeloid cells and adipocytes that survives weight loss. Third, adipocyte-macrophage positive feedback loops, failed biosynthesis of specialized pro-resolving mediators (SPMs), and defective efferocytosis prevent resolution, so systemic low-grade chronic inflammation persists. Fourth, these signals converge on a three-tier sensitization cascade-peripheral (DRG neuro-immune unit), spinal (microglial-astrocytic disinhibition and NMDA-LTP), and supraspinal (descending-control imbalance with vagal-HPA brake failure)-producing four clinically tractable phenotypes: metabolic osteoarthritis, diabetic small-fiber neuropathy, mixed-mechanism low back pain, and sex-dimorphic pain. This framework supports a precision-medicine strategy in which NLRP3 and Na
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.